{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:41:29Z","timestamp":1791906089632,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.thromres.2004.09.004","type":"journal-article","created":{"date-parts":[[2004,12,15]],"date-time":"2004-12-15T15:18:52Z","timestamp":1103123932000},"page":"301-307","source":"Crossref","is-referenced-by-count":18,"title":["Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin"],"prefix":"10.1016","volume":"115","author":[{"given":"Robert F.","family":"Storey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Heptinstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.09.004_bib1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0609.1971.tb01976.x","article-title":"Inhibition of thrombin induced aggregation of human platelets by heparin","volume":"8","author":"Eika","year":"1971","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.thromres.2004.09.004_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI109661","article-title":"Effect of heparin and heparin fractions on platelet aggregation","volume":"65","author":"Salzman","year":"1980","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2004.09.004_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/01.CIR.97.3.251","article-title":"Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor","volume":"97","author":"Xiao","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.09.004_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/09537109609023587","article-title":"Purinergic receptors on blood platelets","volume":"7","author":"Gachet","year":"1996","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2004.09.004_bib5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1046\/j.1365-2141.2000.02208.x","article-title":"The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity","volume":"110","author":"Storey","year":"2000","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2004.09.004_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/09537100120085450","article-title":"Effects of P2Y1 and P2Y12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood","volume":"12","author":"Storey","year":"2001","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2004.09.004_bib7","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1073\/pnas.95.14.8070","article-title":"Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation","volume":"95","author":"Jin","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2004.09.004_bib8","doi-asserted-by":"crossref","first-page":"11544","DOI":"10.1074\/jbc.273.19.11544","article-title":"P2X1 purinoceptor in human platelets. Molecular cloning and functional characterization after heterologous expression","volume":"273","author":"Sun","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2004.09.004_bib9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1074\/jbc.273.4.2030","article-title":"Molecular basis for ADP-induced platelet activation: II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets","volume":"273","author":"Jin","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2004.09.004_bib10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0037-1615596","article-title":"Open multicentre study of the P2T receptor antagonist AR-C69931MX assessing safety, tolerability and activity in patients with acute coronary syndromes","volume":"85","author":"Storey","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.09.004_bib11","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0149-2918(02)85149-9","article-title":"Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction","volume":"24","author":"Jacobsson","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.thromres.2004.09.004_bib12","first-page":"113","article-title":"Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation","volume":"24","author":"Paolini","year":"1993","journal-title":"J. Med."},{"key":"10.1016\/j.thromres.2004.09.004_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1600-0609.1972.tb00937.x","article-title":"On the mechanism of platelet aggregation induced by heparin, protamine and polybrene","volume":"9","author":"Eika","year":"1972","journal-title":"Scand. J. Haematol."},{"key":"10.1016\/j.thromres.2004.09.004_bib14","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1182\/blood.V94.12.4156","article-title":"A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR-1 activating peptide through the late activation of phosphoinositide 3-kinase","volume":"94","author":"Trumel","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2004.09.004_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1055\/s-0037-1614384","article-title":"Role of intracellular signaling events in ADP-induced platelet aggregation","volume":"82","author":"Daniel","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2004.09.004_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/38284","article-title":"Defective platelet activation in G\u03b1q-deficient mice","volume":"389","author":"Offermanns","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2004.09.004_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09537100120058739","article-title":"The platelet P2Y12 receptor as a therapeutic target in cardiovascular disease","volume":"12","author":"Storey","year":"2001","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2004.09.004_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2004.09.004_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/0953710021000024402","article-title":"Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease","volume":"13","author":"Storey","year":"2002","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2004.09.004_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804004955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804004955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T19:00:42Z","timestamp":1586026842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804004955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0049384804004955"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.09.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}